1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Tauopathies in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gratuze, M | 1 |
| Josset, N | 1 |
| Petry, FR | 1 |
| Pflieger, M | 1 |
| Eyoum Jong, L | 1 |
| Truchetti, G | 1 |
| Poitras, I | 1 |
| Julien, J | 1 |
| Bezeau, F | 1 |
| Morin, F | 1 |
| Samadi, P | 1 |
| Cicchetti, F | 1 |
| Bretzner, F | 1 |
| Planel, E | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Tauopathies
| Article | Year |
|---|---|
The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Alzheimer Disease; Animals; Brain; Co | 2019 |